Member Info for StuoftheToon

Very enthused by the NASDAQ listing but there is the impending dilution when the new issue shares hit the market in the morning. It may be that investors are waiting to see what effect this has before taking a position. For me a temporary dip leaves me totally unfazed as I think this is going to be an excellent investment.

Thanks for the update Chesh.

If the science and the tech' is as good as I think it is, DeepVerge will have all on to fend of predators. Amazing work to get this far with the various collaborations, I am sure we are getting noticed!!

What a great read!!!!
Anticipating an exceptional 2021 for Deepverge

Current year expectations for Deepverge are already high. On 11 January 2021, the Group confirmed that Q4 2020 was its first ever profitable (at the EBITDA level) quarter, during which time order books had built strongly with the signing of 12 new contracts for Labskin Services. At the same time, the Board also provided revenue guidance of £10m for 2021 (representing 127% annualised growth on the full year 2020 figures), while noting that several large projects, including two ‘multi-million pound opportunities’ due for decision in coming months offer potential to drive this figure substantially higher still. Today’s news not only reinforces such expectations, but potentially offers to dramatically reset targets. Recognising that the current year will likely see the world transition from one that has struggled to contain the catastrophic effects of a global viral pandemic, to one that needs to urgently understand how to provide rapid, ongoing detection, containment, monitoring and response in a post-Pandemic environment whose principal challenge must be to ensure such outbreaks cannot undermine humankind’s future well-being, Deepverge’s seemingly ideal range of core competences, technologies, innovative skillsets and global reach potentially positions it to enjoy years of exceptional, high margin growth. On 11 January 2021, TPI updated its valuation for Deepverge, indicating a revised figure of £140.6m, or share price target of 84.8p. For now, this remains current, although TPI recognises that Microtox® BT’s full clinical validation followed by rapid progress toward its CE marking in the coming months could lift this substantially higher.

https://twitter.com/i/status/1371854203505770498
Gerard, get this guy on the team!!

Every day is a learning day for her trillsg. This is a great board supporting a great company ...don't change.

Will do Chesh. She is getting the hang of your posts (more than I am). She logs on for the banter on here but doesn't have the confidence to post anything. Had a lovely message from Mr. Gerard (as she refers to him). I told her that the price had dropped recently and she asked if Mr.Gerard would like some more money. I'm sure I saw her go to her purse!

Cheers Paul. As I keep telling her that £250 investment forms part of my inheritance!

Fantastic.. Mum's back in profit. I can now be allowed back in her house!!

Apologies if this has already been highlighted but are any of these EPO concessions detailed in the article ours? I have checked the VAST website but can't find any specific details, (I was thinking Chiadzwa).

https://miningzimbabwe.com/breaking-zim-miners-over-the-moon-as-government-approves-25-epos/

Gerard now writing for The Guardian!!
The concept of taking waste water samples, every five minutes, from a primary school sewage system triggers visions of Gerard's PHD students, sitting cross legged next to the sewage manhole with a test tube on a piece of string and a stopwatch. Now if only there was a real-time monitoring.....!!!????!!!

The plot thickens - good find trillsg!

Nice RNS but lets have some figures please.

Nicely put Paul!

sadmackems57 (love the name by the way), the reason was fully explained in an RNS and clarified by Gerard Brandon, I think on this forum. As an investor I was satisfied with the explanation and an investment in a collaborative partner (Microsaic) made sense to me. I never felt it was abandoning the DVRG ship. I am very upbeat about this share, and as such always look for the positives (but never ignore any warning signs). Still a strong buy for me.

Persistence and due diligence, a good but rare combination.

Excellent research. Thank you so much for sharing.

A great team effort - take a bow Gerard son (and your teams).

When you know what they have in their portfolio it was only a matter of time. As routine surgery re-commences then demand for our products will be pretty high, with the backlog of procedures. I hope our products go on to improve the lives of the people who have had to wait for their surgery.

A canny tick up this morning. I like where this is going!